RDNT

RadNet, Inc. 10-Q Summary: Period Ended June 30, 2010

Business Context and Reporting Period

This report covers the quarterly period ended June 30, 2010. RadNet, Inc. operates 191 diagnostic imaging facilities across seven states, primarily in California, Maryland, Florida, Kansas, Delaware, New Jersey, and New York. The company provides services including MRI, CT, PET, nuclear medicine, mammography, and ultrasound. Operations are reported as a single segment.

Key Financial Metrics

Note: Total Debt calculated as Current portion of notes payable ($8.5M) + Long-term notes payable ($481.9M) + Current capital leases ($11.3M) + Long-term capital leases ($8.6M).

Material Changes vs. Prior Period

• Revenue Growth: Net revenue increased 1.5% year-over-year to $263.1 million. However, revenue from comparable centers (operating in both periods) decreased 4.9% due to a decline in patient scheduling, partially offset by $17.9 million in revenue from newly acquired centers.
• Operating Expenses: Total operating expenses increased 3.6% to $248.9 million. Salaries and professional reading fees rose 7.0%, driven by acquisitions and expansion of breast care centers. Medical supplies expenses decreased 9.7% due to vendor changes and rebates.
• Net Loss Expansion: The net loss widened significantly to $15.9 million from $1.2 million. This deterioration was primarily driven by a $9.9 million loss on extinguishment of debt incurred during the April 2010 refinancing.
• Debt Refinancing: On April 6, 2010, the company completed a $585 million debt refinancing, replacing prior GE Credit Facilities with a new senior secured term loan ($285 million), a revolving credit facility ($100 million), and senior unsecured notes ($200 million).

Guidance, Outlook, and Risks

• Debt Structure: The new credit agreement includes financial covenants (minimum interest coverage, maximum leverage) and mandatory prepayments from excess cash flow. The senior unsecured notes carry a 10.375% coupon.
• Healthcare Reform Impact: The Patient Protection and Affordable Care Act (PPACA) and subsequent Reconciliation Act are expected to decrease revenue from Medicare beneficiaries. Changes include increased equipment utilization factors for advanced imaging (MRI, CT, PET) and reduced reimbursement for multiple images on contiguous body parts.
• Acquisitions: The company continues an acquisition strategy, completing deals for Truxtun Medical Group ($20.3M cash + stock), Sonix Medical Resources facilities ($2.3M), and others during the period.
• Liquidity: Management believes cash flows from operations, combined with the new credit facilities, will be sufficient to satisfy obligations for the next twelve months. Working capital improved significantly to $31.4 million.
• Derivatives: Following the refinancing, interest rate swaps no longer qualify as cash flow hedges. Changes in their fair value are now recognized in earnings, contributing to other expenses.

Key Facts for Investor Verification

• Debt Extinguishment Loss: Verify the $9.9 million non-cash charge related to the April 2010 refinancing, which significantly impacted net income but not operating cash flow.
• Comparable Revenue Decline: Confirm the 4.9% decline in revenue from existing centers and the specific impact of weather conditions and patient scheduling mentioned in management commentary.
• Medicare Reimbursement Risk: Assess the potential long-term revenue impact of the PPACA changes regarding equipment utilization rates and contiguous body part imaging reductions.
• Debt Covenants: Review the specific thresholds for the new interest coverage and leverage ratios to ensure compliance given the high fixed-cost nature of the business.
• Interest Rate Exposure: Note that while the new term loan is fixed, the revolving facility is floating, and the company has recognized losses on interest rate swaps that are no longer designated as hedges.